Advice on recommended inhaler treatment regimens for asthma, and the shift to SABA-free care, and how to embed these regimens in practice ...

The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.

Building upon the 2023 Global Initiative for Asthma (GINA) report, the recently updated British Thoracic Society (BTS)/ ...

After delivering one of its strongest quarters ever, pharmaceutical major Lupin Ltd. is preparing for the next leg of growth, anchored in complex generics, respiratory therapies, and targeted ...

Inhaled corticosteroids pose long-term risks in COPD management, prompting careful screening and potential de-escalation strategies, said Sara Assaf, MD. There are significant long-term systemic risks ...

Setting English primary electronic health data from the Clinical Practice Research Datalink linked with hospital data from Hospital Episode Statistics. Participants 42 820 children aged 5 years or ...

Inhalers that deliver quick relief to patients with asthma and chronic obstructive pulmonary disease (COPD) may be taking a toll on the planet, producing as much climate-warming pollution as more than ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study—the largest to date quantifying inhaler-related emissions ...